FDAnews/CenterWatch Announces -- Pharmaceutical Clinical Trials Transparency and Privacy: Build Brand Trust and Navigate Evolving Regulations Webinar July 23, 2020
Build trust for a brand through clinical trial transparency and protecting patient privacy when sharing clinical trial data.
FALLS CHURCH, Va., July 9, 2020 /PRNewswire-PRWeb/ -- Pharmaceutical Clinical Trials Transparency and Privacy
Build Brand Trust and Navigate Evolving Regulations
An FDAnews/CenterWatch Webinar
Thursday, July 23, 2020 • 11:00 a.m.-12:30 p.m. EDT
https://www.centerwatch.com/pharmacttrans
With new clinical trial transparency regulations from the FDA, European Medicine's Association (EMA) and Health Canada — coupled with the increased need for clinical data due to COVID-19 and trends toward voluntary data-sharing initiatives — a broader and more robust toolkit of capabilities is needed to stay compliant.
For instance, how can one incorporate quantitative anonymization in order to ensure trial participant privacy?
Sarah Lyons, general manager of Privacy Analytics, and Vivien Fagen, director, medical writing and clinical trial disclosure for IQVIA will explain how to build brand trust through clinical trial transparency, navigate evolving transparency regulations and protect patient privacy when sharing clinical trial data:
- Explore current transparency requirements for study publication from the FDA, EMA and Health Canada
- Grasp the link between transparency, privacy and brand trust, and how privacy-preserving data-sharing methods can help sponsors earn trust with internal and external stakeholders, including patients themselves
- Understand new regulatory guidance, EMA Policy 0070 and Health Canada Public Release of Clinical Information, on how to anonymize clinical study reports
- Implement best practices for anonymization to enable trial transparency while protecting participant privacy, including quantitative re-identification risk measurement
- Preserve data utility and protect patients when sharing data voluntarily
Master emerging trends in clinical trial transparency to ensure participant privacy.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Pharmaceutical Clinical Trials Transparency and Privacy
Build Brand Trust and Navigate Evolving Regulations
An FDAnews/CenterWatch Webinar
Thursday, July 23, 2020 • 11:00 a.m.-12:30 p.m. EDT
https://www.centerwatch.com/pharmacttrans
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.centerwatch.com/pharmacttrans
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations
About CenterWatch:
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.
SOURCE CenterWatch
Share this article